 | 2008-Apr-03
Press Release |
 |
ForteBio Announces New Octet RED System for Drug Candidate Characterization and Selection | | [show details] |
|
| MENLO PARK, Calif. - April 3, 2008 — ForteBio®, Inc., a life science company that develops and sells analytical tools to accelerate the development of therapeutic products, today announced the launch of the Octet® RED System, for label-free, real-time kinetic analysis of drug compounds. The new system brings unparalleled ease-of-use, sensitivity, throughput and affordability to the analysis of small molecules, peptides and proteins for research, development and bioprocess...
More... |
|
| 2007-Sep-18
Press Release |
|
ForteBio Announces Executive Change | | [show details] |
|
| MENLO PARK, Calif. — September 18, 2007 — ForteBio, Inc., a rapidly growing life science company that develops and commercializes analytical instruments and consumables to accelerate and improve therapeutics development, announced today that Joseph D. Keegan, Ph. D., has been named president and chief executive officer, beginning September 24, 2007. ForteBio founding CEO Winnie H. Wan, Ph.D., who is credited with building the company into an emerging leader in the label-fr...
More... |
|
| 2007-Aug-20
Press Release |
|
ForteBio Expands International Distribution Network | | [show details] |
|
| MENLO PARK, Calif. — August 20, 2007 — ForteBio, Inc., a leading developer of label-free, real-time systems for biomolecular interaction analysis, announced today that it has signed two new distributors to sell and distribute its Octet System of instruments and related consumables. The company named Bucher Biotec AG, Switzerland, as its exclusive Swiss distributor and Millennium Science Pty Ltd, Australia, as its distribution partner in Australia and New Zealand. The annou...
More... |
|
| 2007-Aug-13
Press Release |
|
ForteBio Strengthens Portfolio with New Biosensors for Research and Development | | [show details] |
|
| MENLO PARK, Calif. — August 13, 2007 — ForteBio, Inc., a leading developer of label-free, real-time systems for biomolecular interaction analysis, today announced two new product extensions to its Octet™ System. The Anti-Murine IgG Biosensor — Quantitation grade, and the Streptavidin High Binding FA Biosensor — Screening grade, extend the Octet System's concentration determination and kinetic analysis capabilities, respectively, broadening the product off...
More... |
|
| 2007-Jun-29
Product Bulletin |
|
New Biosensors expand applications for research and assay development | | [show details] |
|
| In ForteBios' continuing effort to expand the applications on the Octet System, we are launching two new biosensors for the kinetic analysis and concentration determination for research, development and production of antibody and protein therapeutics. The following Screening and Quantitation grade biosensors are now available for use on the Octet System.
Anti-Murine IgG Biosensors - Quantitation Grade
• Determine mouse or rat IgG concentration based on a standard c...
More... |
|
| 2006-Dec-07
Press Release |
|
ForteBio Launches New Biosensors to Increase the Flexibility of the Octet System | | [show details] |
|
| MENLO PARK, Calif. — December 7, 2006 — ForteBio, Inc. announced today the launch of the Amine Reactive and Protein A Biosensors for use on ForteBio's Octet System, a label-free, real-time detection system for the analysis of molecular interactions. The new biosensors expand the menu of Octet applications, providing convenient kinetic analysis and concentration determination for the development of antibody and protein therapeutics.
The ForteBio Octet System is cur...
More... |
|
| 2006-Jul-18
Press Release |
|
ForteBio Adds Bernelle Saperstein to its Management Team | | [show details] |
|
| MENLO PARK, Calif. — July 18, 2006 — ForteBio, Inc., developer of label-free systems for real-time detection and analysis of molecular interactions, said today that Bernelle H. Saperstein has joined the company as Vice President, Manufacturing Operations, a new position. Ms. Saperstein comes to ForteBio from BD-Immunocytometry Systems, where she led a large team responsible for manufacturing and testing reagents for cell analysis. “Bernelle is an extremely knowled...
More... |
|
| 2005-Nov-29
Press Release |
|
ForteBio Introduces the Octet System
for Antibody and Protein Therapeutics Development | | [show details] |
|
| MENLO PARK, Calif. — November 29, 2005 — ForteBio, Inc. today announced the commercial introduction of the company's first product, the Octet™ System for label-free, real-time detection and analysis of molecular interactions. The next generation of analytical tools for life science research, Octet accelerates antibody development by generating real-time quantitative and kinetics results quickly and easily. Ready to use, consumable biosensors provide a cost-effective wa... More... |
|
| 2005-Oct-26
Press Release |
|
ForteBio Raises 17.3 Million in Series B Financing - Funding Will Support Launch | | [show details] |
|
| MENLO PARK, Calif. — October 26, 2005 — ForteBio, Inc., a life sciences company
providing tools for the detection and analysis of biomolecules and their interactions, today
announced the close of a $17.3 million Series B Preferred Stock financing. The round was
led by The Vertical Group, a New Jersey-based venture capital firm that is focused on the
fields of medical technology and biotechnology. All of the company's existing investors,
Agilent Ventures, Alloy Ventures, L... More... |
|
